GlassScriptPhysician profile
Boris Rubashkin
NPI 1750473047
$3,750.49
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,945 · 2020: $546 · 2021: $190 · 2022: $26.99 · 2024: $43.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $43.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $43.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $608.65 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $594.46 | 2019-2020 | |
| Alkermes, INC. | $469.27 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $294.24 | 2019-2021 | |
| Allergan, INC. | $274.74 | 2019-2020 | |
| Lundbeck LLC | $224.99 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $219.54 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $193.76 | 2019-2020 | |
| Neurocrine Biosciences, INC. | $166.55 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $155.78 | 2019-2020 | |
| Indivior INC. | $147.54 | 2019-2020 | |
| Abbvie INC. | $74.64 | 2021-2024 | |
| Neos Therapeutics, LP | $57.04 | 2019 | |
| Shire North American Group INC | $46.36 | 2019 | |
| Owp Pharmaceuticals, INC. | $45.02 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $35.96 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.83 | 2020 | |
| Novo Nordisk INC | $25.09 | 2024 | Rybelsus, Ozempic |
| Ironshore Pharmaceuticals INC. | $18.29 | 2019 | |
| Jazz Pharmaceuticals INC. | $14.71 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $14.06 | 2019 | |
| Adlon Therapeutics L.P. | $12.77 | 2020 | |
| Bausch Health US, LLC | $12.16 | 2020 | |
| Arbor Pharmaceuticals, INC. | $11.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Boris Rubashkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.